---
title: "STAT+: AstraZeneca invests $2 billion in Summit Therapeutics"
description: "AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates."
author: "Meghana Keshavan"
section: health
published: 2026-10-06T13:33:54.747394+00:00
canonical: https://valorandventures.media/article/aa7634fb-0d77-427f-abce-1a3859a01eb3
publisher: "Valor & Ventures Media"
source: "STAT News"
source_url: https://www.statnews.com/2026/09/29/biotech-news-astrazeneca-invests-2-billion-in-summit-therapeautics/?utm_campaign=rss
access: free
---

# STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

*AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.*

## Article

---
Meghana Keshavan · STAT News · Photo: Anthony Devlin/Getty Images for AstraZeneca

---

Originally published by STAT News: https://www.statnews.com/2026/09/29/biotech-news-astrazeneca-invests-2-billion-in-summit-therapeautics/?utm_campaign=rss